文献速递前列腺增生与排尿功能障碍男科与性医学

削减成本而非医疗:男性健康药物可负担新模式

Cutting Costs, Not Care: New Models for Affordable Men's Health Medications.
PubMed 文献 · Urology · 2025-11-14

本研究比较Mark Cuban Cost Plus Drug Company(CDPC)和GoodRx与Medicaid在男性健康药物上的成本节省。CDPC除舍曲林30粒装和克罗米芬所有规格外均比Medicare便宜,且除部分帕罗西汀剂量和60粒装坦索罗辛外均比GoodRx便宜。

要点

  • CDPC为多数男性健康药物提供显著成本节省
  • 勃起功能障碍治疗药物节省幅度最大
  • 克罗米芬和舍曲林30粒装例外,CDPC不更便宜

核心结论

  • 与Medicare和GoodRx相比,CDPC在男性健康药物上可提供显著成本节省。

研究设计与样本

  • 回顾性成本分析,纳入九种男性健康常用药物,基于2022年Medicare公开支出数据。

主要发现

  • CDPC除舍曲林30粒装和克罗米芬所有规格外均比Medicare便宜。
  • 勃起功能障碍治疗药物节省幅度最大。
  • CDPC除部分帕罗西汀剂量和60粒装坦索罗辛外均比GoodRx便宜。

临床怎么用

  • 对于男性健康药物,可考虑通过CDPC采购以降低药品支出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the cost savings that the Mark Cuban Cost Plus Drug Company (CDPC) and GoodRx could provide, in comparison to Medicaid, for drugs commonly prescribed in men's health-related conditions: erectile dysfunction, benign prostatic hyperplasia, premature ejaculation, and male infertility. METHODS: We reviewed several of the most commonly prescribed drugs for each indication at various doses, including Tamsulosin, Anastrozole, Clomiphene, Sildenafil, Tadalafil, Vardenafil, Finasteride, Paroxetine, and Sertraline. Using publicly available Medicare data sheets, we determined the total Medicare spending in 2022 for each drug and the total number of drug units dispensed. We then calculated the cost per unit using CPDC and GoodRx pricing and multiplied these by the total number of units dispensed by Medicare. This yielded the potential total spending on each drug if purchased through CPDC or GoodRx. Finally, we compared Medicare's actual spending with the estimated spending under each alternative platform. RESULTS: The total 2022 Medicare cost for the nine studied drugs was $970 million. If purchased through CPDC, the estimated total costs for 30-, 60-, and 90-count fills would have been $760 million, $447 million, and $340 million, respectively. CPDC was cheaper than Medicare for all drugs except sertraline at 30-count fills, and clomiphene at all count fills. The largest savings were seen in erectile dysfunction treatments. CPDC was also consistently cheaper than GoodRx, except for select paroxetine doses and 60-count tamsulosin. CONCLUSION: CPDC provides significant cost savings on men's health medications compared to Medicare and GoodRx.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Tranchina SP, Moreland HE, Snipes MC, et al. Cutting Costs, Not Care: New Models for Affordable Men's Health Medications. Urology. 2025. PMID: 41242580. doi:10.1016/j.urology.2025.11.233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。